HEALTH IN TECH INC-CLASS A (HIT) Forecast, Price Target & Analyst Ratings

NASDAQ:HITUS42217D1028

Current stock price

1.77 USD
-0.03 (-1.67%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEALTH IN TECH INC-CLASS A (HIT).

Forecast Snapshot

Consensus Price Target

Price Target
$4.59
+ 159.32% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 25, 2026
Period
Q4 / 2025
EPS Estimate
-$0.01
Revenue Estimate
7.346M

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.59
Upside
+ 159.32%
From current price of $1.77 to mean target of $4.59, Based on 5 analyst forecasts
Low
$4.55
Median
$4.59
High
$4.73

Price Target Revisions

1 Month
0.00%
3 Months
16.13%

Price Target Summary

5 Wall Street analysts provided a forecast for the next 12 months for HIT. The average price target is 4.59 USD. This implies a price increase of 159.32% is expected in the next year compared to the current price of 1.77.
The average price target has been revised upward by 16.13% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

HIT Current Analyst RatingHIT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

HIT Historical Analyst RatingsHIT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
HIT was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about HIT.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed HIT. So this is just the average opinion of a couple of analysts.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-06-26Maxim GroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 25, 2026
Period
Q4 / 2025
EPS Estimate
-$0.01
Revenue Estimate
7.346M
Revenue Q2Q
49.78%
EPS Q2Q
N/A
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-11.42%
EPS (1 Month)
N/A
EPS (3 Months)
-166.67%

Next Earnings Summary

HIT is expected to report earnings on 3/25/2026. The consensus EPS estimate for the next earnings is -0.01 USD and the consensus revenue estimate is 7.35M USD.
The next earnings revenue estimate has been revised downward by 11.42% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
HIT revenue by date.HIT revenue by date.
5.77M19.152M
231.93%
19.491M
1.77%
32.696M
67.75%
42.456M
29.85%
80.914M
90.58%
EBITDA
YoY % growth
HIT ebitda by date.HIT ebitda by date.
205.6K3.722M
1,710.51%
1.531M
-58.87%
3.717M
142.78%
2.511M
-32.45%
17.208M
585.30%
EBIT
YoY % growth
HIT ebit by date.HIT ebit by date.
205.6K3.383M
1,545.48%
989.9K
-70.74%
982.73K
-0.72%
102.01K
-89.62%
14.239M
13,858.44%
Operating Margin
HIT operating margin by date.HIT operating margin by date.
3.56%17.66%5.08%3.01%0.24%17.60%
EPS
YoY % growth
HIT eps by date.HIT eps by date.
N/AN/AN/A0.02-0.01
-133.33%
0.19
3,900.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.01-0.01
-201.00%
0.03
203.00%
0.00
-100.00%
0.01
200.00%
0.02
300.00%
0.06
100.00%
0.080.11
1,000.00%
Revenue
Q2Q % growth
7.346M
49.78%
9.301M
15.97%
12.098M
29.89%
10.484M
23.49%
11.661M
58.74%
14.379M
54.60%
17.73M
46.55%
21.86M
108.51%
26.955M
131.16%
EBITDA
Q2Q % growth
117.16K
-47.88%
77.77K
-87.39%
2.356M
136.29%
912.03K
-7.27%
1.309M
1,017.28%
2.144M
2,656.85%
3.849M
63.37%
4.853M
432.11%
6.365M
386.25%
EBIT
Q2Q % growth
-733.26K
-131.82%
-533.28K
-210.94%
1.392M
91.97%
-112.11K
-122.72%
223.21K
130.44%
997.88K
287.12%
2.642M
89.80%
3.586M
3,298.64%
5.037M
2,156.62%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HIT Yearly Revenue VS EstimatesHIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
HIT Yearly EPS VS EstimatesHIT Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.05 0.1 0.15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
148.54%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
60.72%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
159.05%
EBIT Next 5 Year
N/A

HEALTH IN TECH INC-CLASS A / HIT Forecast FAQ

What is the average price target for HEALTH IN TECH INC-CLASS A (HIT) stock?

5 analysts have analysed HIT and the average price target is 4.59 USD. This implies a price increase of 159.32% is expected in the next year compared to the current price of 1.77.

When does HEALTH IN TECH INC-CLASS A (HIT) report earnings?

HEALTH IN TECH INC-CLASS A (HIT) will report earnings on 2026-03-25.

What are the consensus estimates for HIT stock next earnings?

The consensus EPS estimate for the next earnings of HEALTH IN TECH INC-CLASS A (HIT) is -0.01 USD and the consensus revenue estimate is 7.35M USD.

What is the expected long term growth rate for HIT stock?

The expected long term growth rate for HEALTH IN TECH INC-CLASS A (HIT) is 60.72%.